Physician profile
Eldon R Becker
NPI 1023083797
$1,252.33
in general payments reported to CMS, 2019-2025
18 companies · $250 in 2025
The $250 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $51.90 · 2021: $13.34 · 2022: $66.91 · 2023: $336 · 2024: $371 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $957.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $956.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $378.24 | 2019-2025 | Evenity, Prolia, Otezla |
| Novo Nordisk INC | $221.67 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $190.25 | 2023-2025 | Mounjaro, Zepbound, Basaglar |
| Daiichi Sankyo INC. | $89.60 | 2022-2024 | Injectafer |
| Exact Sciences Corporation | $67.79 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Grifols USA, LLC | $51.17 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.56 | 2023 | |
| Boston Scientific Corporation | $30.85 | 2024 | Watchman Flx |
| Merck Sharp & Dohme LLC | $26.18 | 2020-2025 | Vaxneuvance, Capvaxive, Gardasil 9 |
| Alexion Pharmaceuticals, INC. | $22.55 | 2022 | |
| Davol INC. | $20.54 | 2023 | Phasix Mesh |
| Glaxosmithkline, LLC. | $19.35 | 2019 | |
| Abbvie INC. | $18.02 | 2025 | |
| Axonics, INC. | $17.71 | 2024 | Axonics |
| Vertex Pharmaceuticals Incorporated | $17.24 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.16 | 2025 | |
| Kci USA, INC. | $13.34 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eldon Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.